Partners
Partner
Here’s the deal. We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
Expertise Partner
With a relentless mission to empower those seeking answers to life’s important scientific questions, Beckman Coulter Life Sciences is a preferred laboratory partner providing automation and innovation solutions for Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling workflows. With a legacy dating back to 1935, our technologies reduce manual laboratory processes and can provide greater speed, accuracy, and advanced analytics to accelerate answers with a guiding focus to improve patient care and enable pioneering discoveries. Beckman Coulter Life Sciences is headquartered in Indianapolis, Indiana with 11 operational hubs around the world and employs more than 3,300 associates with more than 300,000 systems installed globally.
Expertise Partner
leon-nanodrugs GmbH (LEON) is a technology provider specializing in equipment for the manufacturing of nanoparticle-based drug products, including RNA-based lipid nanoparticles (LNPs). Our technology platform, featuring the modular FR-JET ® mixing reactor, enables a seamless transition from R&D to commercial-scale manufacturing, eliminating common challenges associated with tech transfer between scales. Our portfolio of devices, NANOlab® for process development, NANOme® and NANOus® for GMP aseptic manufacturing, enable faster route to clinical batches and are suitable for both individualised scales and commercial production. For individualized mRNA therapies, NANOme® is a groundbreaking piece of equipment designed to meet stringent regulatory requirements. Featuring fully GMP-compliant, closed, and automated aseptic processing with single-use sterile fluid paths, NANOme® ensures rapid, back-to-back manufacturing and contamination-free production of patient-specific batches. LEON’s technology platform empowers drug developers to optimize their manufacturing processes effortlessly, ensuring rapid progression from development to commercial manufacturing.
Exhibition Partner
Founded in 2016, ONI is now a leading and rapidly growing life science company redefining the boundaries of scientific discovery with super-resolution microscopy. The Nanoimager, ONI’s flagship product, is the world’s first desktop super-resolution microscope, capable of visualizing, tracking and imaging individual molecules in living cells with 20 nm resolution. Each team at ONI – from scientists to software engineers to sales teams – wants to create and provide innovative technologies that will empower researchers and users alike. We want to accelerate human discovery and fight disease and in doing so drive super-resolution microscopy to novel frontiers